Chronic Lymphocytic Leukemia

>

The OncLive Chronic Lymphocytic Leukemia condition center page is a comprehensive resource for clinical news and expert insights on treatment advances and ongoing research in chronic lymphocytic leukemia. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs and updates with chronic lymphocytic leukemia therapy.

Latest News

Orelabrutinib Plus FCG Generates Rapid Molecule Remissions in CLL
First-Line Orelabrutinib Plus FCG Generates Rapid Molecule Remissions in CLL

July 3rd 2024

Orelabrutinib plus FCG led to undetectable MRD in all patients with untreated chronic lymphocytic leukemia who completed 12 cycles of therapy

Consuelo Bertossi, MD, of University Hospital Ulm in Germany
TP53 Mutations Are Associated With Unfavorable Prognosis in CLL

June 18th 2024

Arliene Ravelo Mangalindan, MPH, director, Oncology Health Economics & Outcomes Research, Genentech
Patients With CLL Place the Most Value on Treatments That Prolong PFS

June 18th 2024

Stephen Opat, of Monash Health
Sonrotoclax Plus Zanubrutinib Is Safe, Efficacious in Relapsed/Refractory CLL/SLL

June 17th 2024

Jing-Zhou Hou, MD, PhD, of UPMC Hillman Cancer Center
Acalabrutinib and Zanubrutinib Both Best Ibrutinib in Real-World Safety and Efficacy CLL/SLL Outcomes

June 17th 2024

<1
...
57